Fundascopic examination has limited benefit for management of hypertension

International Heart Journal

Volumn 48, Issue 2, 2007, Pages 187-194

  Helvaci, Mehmet Rami ^a   Ozcura, Fatih ^a   Kaya, Hasan ^b   Yalcin, Atilla ^c  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Hypertension; Hypertensive retinopathy

Indexed keywords

LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; HYPERTENSIVE CRISIS; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; OPHTHALMOSCOPY; PREVALENCE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RISK FACTOR; WEIGHT REDUCTION; CASE CONTROL STUDY; EYE FUNDUS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RETINA DISEASE;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FUNDUS OCULI; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OPHTHALMOSCOPY; PREVALENCE; REPRODUCIBILITY OF RESULTS; RETINAL DISEASES;

EID: 34247116831     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.187     Document Type: Article

References (22)

1. Ezzati M, Lopez AD, Rodgers A, Vander Hoom S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2000; 360: 1347-60. (Review)
2. Chobanian AV, Bakris GL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
3. Helvaci MR, Seyhanli M. What a high prevalence of white coat hypertension in society! Intern Med 2006; 45: 671-4.
4. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-48. (Review)
5. Mandava N, Yunnuzzi LA. Hypertensive Retinopathy. In: Regillo CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease: The Essentials. New York: Thieme; 1999: 193-6.
6. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-421.
7. Ohkubo T, Asayama K, Kikuya M, et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099-104.
8. Ridker PM, Libby P. Risk Factors for Atherothrombotic Disease. In: Douglas P. Zipes, Peter Libby, Robert O. Bonow, Eugene Braunwald, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2005: 939-58.
9. Cuspidi C, Salerno M, Salerno DE, et al. High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinography. Blood Press 2004; 13:25-30.
10. van den Born BJ, Schlingemann RO, Hoekstra JB, van Montfrans GA. Routine funduscopic examination in hypertensive patients not useful. Ned Tijdschr Geneeskd 2004; 148: 464-8. (Review)
11. Raczynska K, Potaz P, Aleszewicz-Baranowska J. Epidemiology of hypertensive retinopathy in young patients after coarctation of the aorta repair. Klin Oczna 2004; 106: 456-9. (Polish)
12. Fuchs FD, Maestri MK, Bredemier M, et al. Study of the use usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9: 547-51.
13. Takiuchi S, Kamide K, Miwa Y, et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18: 17-23.
14. Torun D, Sezer S, Arat Z, Pelit A, Yigit F, Ozdemir FN. The frequency of combined target organ damage and the beneficial effect of ambulatory blood pressure monitoring in never treated mild-to-moderate hypertensive patients. Int Heart J 2005; 46: 1073-82.
15. Luft FC, Agrawal B. Microalbuminuria as a predictive factor for cardiovascular events. J Cardiovasc Pharmacol 1999; 33: S11-5; discussion S41-3.
16. Palatini P, Penzo M, Bongiovi S, Canali C, Pessina AC. Role of ophthalmoscopy in arterial hypertension: a problem revisited. Cardiologia 1991; 36: 713-22. (Italian)
17. Skalina ME, Annable WL, Kliegman RM, Fanaroff AA. Hypertensive retinopathy in the newborn infant. J Pediatr 1983; 103: 781-6.
18. de Carvalho MH, Colaco AL, Fortes; ZB. Cytokines, endothelial dysfunction, and insulin resistance. Arq Bras Endocrinol Metabol 2006; 50: 304-12.
19. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26. (Review)
20. Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 1995; 332: 635-41.
21. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Hypertension, microallbuminuria and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.
22. Rudnichi A, Safar M, Asmar R, Guize L, Benetos A. Prevalence of cardiovascular risk factors in a French population. J Hypertens 1998; 16: S85-90.